A bill to hold insulin manufacturers accountable for excessive increases in prices from U-S Senator Tina Smith now has bipartisan support after Republican Senator Kevin Cramer of North Dakota has signed on.

“Insulin has been around for almost a hundred years and today there are only three manufacturers and the average price of insulin has doubled between 2012 and 2016 so they’re making billions of dollars off of people who need their products to stay alive and I think that’s unacceptable and we need to change that.”

The bill would provide emergency access to insulin for people in Minnesota and across the country. Smith plans to introduce the bill Thursday.